Le Lézard
Classified in: Health
Subjects: NPT, CHI, LEG, AVO, MAT

Congress Should Pass Tobacco 21 Legislation Free of Special Interest Provisions for Tobacco Companies

WASHINGTON, April 18, 2019 /PRNewswire/ -- The Campaign for Tobacco-Free Kids strongly supports effective federal legislation to raise the tobacco age to 21 nationwide and supported the bills introduced in the last Congress by Sen. Brian Schatz and Rep. Diana DeGette, which we understand will be reintroduced in the near future. We have not seen the language of the bill that Senate Majority Leader Mitch McConnell (R-KY) announced he will introduce, so we cannot comment on that specific legislation.

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

While we strongly support raising the tobacco age to 21, we are deeply concerned that tobacco companies have worked to add special interest provisions to state and federal Tobacco 21 bills that shield the industry from other regulations to protect kids and public health, such as prohibitions on flavored tobacco products. It is critical that Congress enact strong Tobacco 21 legislation that is free of special interest provisions that benefit the industry.

At the state level, tobacco companies have worked to include provisions in Tobacco 21 bills that block local regulation of tobacco products, including curbs on flavored tobacco products. Arkansas recently enacted a Tobacco 21 law with such a preemption provision, and other states are considering similar measures.

At the federal level, we also oppose the Tobacco 21 bill recently introduced by Rep. Robert Aderholt (R-AL) because it includes a provision that could benefit tobacco giants Philip Morris International and Altria at the expense of kids and public health. This provision creates a new definition of "vapor product" that would include the IQOS heated tobacco product, which Philip Morris International is currently seeking FDA authorization to market in the United States (with Altria as the U.S. distributor). If this definition is adopted broadly by the FDA, the impact would be to classify IQOS and similar products as vapor products rather than as cigarettes. This would allow IQOS to escape stronger regulations on cigarettes, such as existing prohibitions on flavors and restrictions on marketing that appeals to kids (including prohibitions on sponsorships of music, sports and other events). Classifying IQOS and similar products as vapor products rather than cigarettes would clear the way for tobacco companies to market these products using flavors and tactics that appeal to kids.

While an important step, Tobacco 21 legislation should be a complement to ? and not a substitute for ? other measures to reverse the youth e-cigarette epidemic and continue reducing youth tobacco use. It is especially critical that action be taken to prohibit the flavored products that have driven the youth e-cigarette epidemic. Until Congress or the FDA acts, states and localities should ramp up their efforts to prohibit these flavored products. That is why it is imperative for Congress and state legislatures to reject tobacco industry efforts to use Tobacco 21 as a vehicle to block effective regulations such as prohibitions on flavored products.

We also urge Congress not to exempt active military personnel from Tobacco 21 legislation as Sen. McConnell is proposing, particularly in light of the military's recognition that tobacco use harms troop readiness and health and costs the government billions in health care costs annually. The military is actively working to reduce tobacco use within its ranks, and Congress should support these efforts by passing a Tobacco 21 bill without a military exemption.


SOURCE Campaign for Tobacco-Free Kids

These press releases may also interest you

at 12:00
Thought leaders from Arizona-based Maricopa Integrated Health System and nThrive will share how a holistic approach to denials management can help providers thrive in the new clinically-driven revenue cycle management environment. Kathie Kirkland,...

at 11:58
Synergistic Therapeutics LLC has recently announced issuance of a U.S. Patent for a topical solution that slows hair loss and generates new hair growth in men and women(1,2). Synergistic Therapeutics LLC, a Florida-based company formed in 2015,...

at 11:57
Centene Corporation ("Centene") and WellCare Health Plans, Inc. ("WellCare") today announced that the stockholders of both companies approved all proposals regarding Centene's pending acquisition of WellCare pursuant to the definitive merger...

at 11:45
The "Market Spotlight: Eating Disorders" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Eating Disorders market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent...

at 11:40
John Weiss & Son, the leading manufacturer and distributor of gold-standard ophthalmic micro-surgical instruments and procedures, is pleased to announce the creation of a brand new product information section on its website, which is now live...

at 11:31
The Honourable Eileen E. Gillese, Commissioner of the Public Inquiry into the Safety and Security of Residents in the Long-Term Care Homes System has announced that she will release her final Report, complete with Recommendations, at noon on...

News published on 18 april 2019 at 15:25 and distributed by: